Cite
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice.
MLA
Jangra, Sonia, et al. “Multicomponent Intranasal Adjuvant for Mucosal and Durable Systemic SARS-CoV-2 Immunity in Young and Aged Mice.” NPJ Vaccines, vol. 8, no. 1, June 2023, p. 96. EBSCOhost, https://doi.org/10.1038/s41541-023-00691-1.
APA
Jangra, S., Landers, J. J., Laghlali, G., Rathnasinghe, R., Warang, P., Park, S.-C., O’Konek, J. J., Singh, G., Janczak, K. W., García-Sastre, A., Arya, N., Karadag, D., Baker, J. R., Jr, Schotsaert, M., & Wong, P. T. (2023). Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice. NPJ Vaccines, 8(1), 96. https://doi.org/10.1038/s41541-023-00691-1
Chicago
Jangra, Sonia, Jeffrey J Landers, Gabriel Laghlali, Raveen Rathnasinghe, Prajakta Warang, Seok-Chan Park, Jessica J O’Konek, et al. 2023. “Multicomponent Intranasal Adjuvant for Mucosal and Durable Systemic SARS-CoV-2 Immunity in Young and Aged Mice.” NPJ Vaccines 8 (1): 96. doi:10.1038/s41541-023-00691-1.